Neos Therapeutics Inc. (NASDAQ: NEOS)Penny Stocks To Watch #1: PharmaDrug Inc.
When you think about biotech, the first thing that might come to mind are labs designed for developing cancer treatments or vaccines. But have you thought about how this market niche has evolved over the last few years? With the inclusion of things like ânatural medicines,â weâve seen everything from cannabis to psychedelics being explored by companies. In this case, PharmaDrug is concentrating on both.
Specific to the pharmaceutical market potential of alternative medicines, the studies focusing on psychedelics primarily target mental health concerns. Weâre talking about a market (central nervous system therapeutics) worth nearly $205 billion by 2028. While the âcannabis playâ for PharmaDrug focuses on the German market, its advancement in R&D for psychedelics is getting much more attention. Furthermore, the company isnât âjust another mushroom stock.â Itâs targeting the use of N, N-Dimethyltryptamine, better known as DMT, in treating certain neuropsychiatric and neurological disorders.PharmaDrug In The News